Among the scant evidence supporting the oncosuppressive role of PPARβ/δ, its ability to decrease FAO and disrupt tumor proliferation in prostate cancer cells is accepted, but only in absence of its ligands (Figure 2C). This evidence concerns the gene PPARD and prostate carcinoma.